Revvity (NYSE:RVTY) Issues FY 2026 Earnings Guidance

Revvity (NYSE:RVTY) issued an update on its FY 2026 earnings guidance on Tuesday. The company provided earnings per share guidance of 5.300-5.400 for the period, compared to the consensus estimate of 5.250. The company issued revenue guidance of $2.8 billion-$2.9 billion, compared to the consensus revenue estimate of $2.8 billion.

Revvity Price Performance

Shares of RVTY stock traded down $2.94 on Tuesday, reaching $112.28. The company had a trading volume of 1,232,315 shares, compared to its average volume of 1,380,012. The stock has a market capitalization of $12.53 billion, a PE ratio of 53.60, a price-to-earnings-growth ratio of 2.21 and a beta of 1.07. The company has a quick ratio of 1.41, a current ratio of 1.72 and a debt-to-equity ratio of 0.37. Revvity has a one year low of $81.22 and a one year high of $118.30. The business’s 50-day moving average is $106.88 and its 200 day moving average is $99.92.

Revvity (NYSE:RVTY) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $1.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.21 by $0.20. Revvity had a net margin of 8.26% and a return on equity of 8.00%. The firm’s revenue was down 1.3% on a year-over-year basis. During the same quarter last year, the firm posted $1.18 EPS. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. Equities research analysts forecast that Revvity will post 5.25 EPS for the current fiscal year.

Revvity Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Friday, October 23rd will be paid a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Friday, October 23rd. Revvity’s dividend payout ratio is presently 13.40%.

Analyst Ratings Changes

Several equities analysts have commented on the company. Sanford C. Bernstein initiated coverage on Revvity in a research report on Friday, June 26th. They issued a “market perform” rating and a $115.00 target price for the company. JPMorgan Chase & Co. dropped their price objective on shares of Revvity from $96.00 to $90.00 and set a “neutral” rating for the company in a report on Wednesday, May 6th. The Goldman Sachs Group decreased their price target on shares of Revvity from $110.00 to $95.00 and set a “neutral” rating for the company in a research report on Tuesday, April 14th. Weiss Ratings raised shares of Revvity from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday. Finally, Wall Street Zen downgraded Revvity from a “buy” rating to a “hold” rating in a report on Saturday, April 18th. Three investment analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Revvity presently has an average rating of “Hold” and a consensus price target of $108.36.

Institutional Investors Weigh In On Revvity

Large investors have recently modified their holdings of the company. Price T Rowe Associates Inc. MD grew its holdings in Revvity by 5.3% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 8,606,637 shares of the company’s stock worth $832,693,000 after acquiring an additional 434,570 shares during the period. Morgan Stanley increased its holdings in Revvity by 29.6% in the fourth quarter. Morgan Stanley now owns 2,844,464 shares of the company’s stock worth $275,202,000 after purchasing an additional 650,083 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in Revvity by 22.9% in the fourth quarter. Dimensional Fund Advisors LP now owns 2,612,116 shares of the company’s stock valued at $252,727,000 after buying an additional 486,159 shares during the period. Invesco Ltd. lifted its stake in Revvity by 15.7% in the third quarter. Invesco Ltd. now owns 2,553,515 shares of the company’s stock valued at $223,816,000 after buying an additional 346,313 shares during the period. Finally, UBS Group AG boosted its holdings in shares of Revvity by 22.3% during the 3rd quarter. UBS Group AG now owns 2,179,505 shares of the company’s stock worth $191,034,000 after buying an additional 397,160 shares in the last quarter. 86.65% of the stock is currently owned by institutional investors and hedge funds.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.